Detailed price information for Ocular Therapeut (OCUL-Q) from The Globe and Mail including charting and trades.
A novel intravitreal axitinib hydrogel demonstrated durable disease control in patients with treatment-naive neovascular age-related macular degeneration (AMD), with superior maintenance of visual ...
Practicing ophthalmologists have an amazing legacy of catalyzing innovation to enhance our ability to retain, restore and ...
Regulatory clearance adds a 1,400-mg subcutaneous CD38 antibody option using CirCLIQ on-body delivery or provider-administered injection, maintaining the same active medicine as the IV formulation.
Immune checkpoint inhibitors (ICIs) have transformed oncology, enabling patients with previously untreatable malignancies to achieve durable responses. However, as the use of agents such as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results